Home › Cancro (tutti i tipi) › Pennsylvania › Pittsburgh
Studi clinici su Cancro (tutti i tipi) a Pittsburgh, PA
41 studi su Cancro (tutti i tipi) cercano partecipanti presso sedi a Pittsburgh e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
In reclutamentoFase 3
- Allegheny Health Network, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
In reclutamento
- UPMC Hillman Cancer Center, Pittsburgh
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
In reclutamentoStudio osservazionale
- Allegheny General Hospital, Pittsburgh
A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
In reclutamento
- AHN Allegheny General Hospital, Pittsburgh
- Allegheny General Hospital, Pittsburgh
EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer
In reclutamento
- AHN Allegheny General Hospital, Pittsburgh
- AHN Allegheny General Hospital, Pittsburgh
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
In reclutamentoFase 1
- UPMC Cancer Centers, Pittsburgh
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
In reclutamentoFase 3
- Allegheny General Hospital (AGH)-Allegheny Singer Research Institute, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- Allegheny Health Network, Pittsburgh
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
In reclutamentoFase 2/3
- UPMC Cancer Pavillion, Pittsburgh
Collection of Tissue Samples for Cancer Research
In reclutamentoStudio osservazionale
- University of Pittsburgh Medical Center, Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
In reclutamentoFase 1/2
- Research Site, Pittsburgh
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- UPMC Hillman Cancer Center, Pittsburgh
Project: Every Child for Younger Patients With Cancer
In reclutamentoStudio osservazionale
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Abatacept in Immune Checkpoint Inhibitor Myocarditis
In reclutamentoFase 3
- Allegheny-Singer Research Institution, Pittsburgh
Biennial CEM in Women With a Personal History of Breast Cancer
In reclutamentoVolontari sani benvenuti
- Magee-Womens Hospital, Pittsburgh
- Hillman Cancer Center at Shadyside, Pittsburgh
- UPMC Magee-Womens Imaging - Bethel Park, Bethel Park · a 8 mi di distanza
- e altri 3
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
In reclutamento
- AHN Allegheny General Hospital, Pittsburgh
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
In reclutamento
- University of Pittsburgh Medical Center (UPMC) Cancer Center, Pittsburgh
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
In reclutamentoFase 2
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Investigating Real-Time Immunotherapy Symptoms Study
In reclutamento
- UPMC Hillman Cancer Center, Pittsburgh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
In reclutamentoFase 2
- 127, Pittsburgh
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- University of Pittsburg Medical Center _UPMC Hillman Cancer Center, Pittsburgh
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
In reclutamentoStudio osservazionale
- AHN CI Exercise Oncology and Resiliency Center, Pittsburgh
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
In reclutamentoFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Childhood Cancer Survivor Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Children's Hospital of Pittsburgh, Pittsburgh
Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors
In reclutamento
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
In reclutamentoFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
In reclutamentoFase 1
- UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
In reclutamentoFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
In reclutamento
- Magee-Womens Hospital, Pittsburgh
Testicular Tissue Cryopreservation for Fertility Preservation
In reclutamento
- Magee-Womens Hospital, Pittsburgh
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
In reclutamentoFase 1
- UPMC Hillman Cancer Center, Pittsburgh
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
In reclutamentoFase 1/2
- UPMC Hilman Cancer Center, Pittsburgh
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
In reclutamentoStudio osservazionale
- Allegheny Health Network, Pittsburgh
Ovarian Tissue Cryopreservation for Fertility Preservation
In reclutamentoStudio osservazionale
- Magee-Womens Hospital, Pittsburgh
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
In reclutamentoFase 2
- Allegheny Health Network West Penn Hospital, Pittsburgh
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
In reclutamento
- Allegheny General Hospital, Pittsburgh
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
In reclutamento
- Allegheny General Hospital, Pittsburgh
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
In reclutamento
- AHN West Penn Hospital, Pittsburgh
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
In reclutamentoStudio osservazionale
- University of Pittsburgh Medical Center, Pittsburgh
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Studi su Cancro (tutti i tipi) in altre città
- Houston, TX121 studi
- New York City, NY109 studi
- Boston, MA85 studi
- Los Angeles, CA74 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Washington, DC58 studi
- Durham, NC58 studi
- Chicago, IL51 studi
- Atlanta, GA49 studi
- Seattle, WA49 studi
- Arlington, VA48 studi
Altri studi a Pittsburgh
- Cancro del polmone non a piccole cellule48 studi
- Cancro al seno39 studi
- Cancro colorettale32 studi
- Cancro metastatico31 studi
- Melanoma31 studi
- Cancro ovarico30 studi
- Cancro dell'endometrio23 studi
- Cancro alla prostata23 studi
- Cancro ai polmoni23 studi
- Carcinoma a cellule squamose della testa e del collo22 studi
- Ictus22 studi
- Depressione22 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.